Natural-product-derived fragments for fragment-based ligand discovery
- 2 December 2012
- journal article
- Published by Springer Science and Business Media LLC in Nature Chemistry
- Vol. 5 (1), 21-28
- https://doi.org/10.1038/nchem.1506
Abstract
Fragment-based ligand and drug discovery predominantly employs sp(2)-rich compounds covering well-explored regions of chemical space. Despite the ease with which such fragments can be coupled, this focus on flat compounds is widely cited as contributing to the attrition rate of the drug discovery process. In contrast, biologically validated natural products are rich in stereogenic centres and populate areas of chemical space not occupied by average synthetic molecules. Here, we have analysed more than 180,000 natural product structures to arrive at 2,000 clusters of natural-product-derived fragments with high structural diversity, which resemble natural scaffolds and are rich in sp(3)-configured centres. The structures of the cluster centres differ from previously explored fragment libraries, but for nearly half of the clusters representative members are commercially available. We validate their usefulness for the discovery of novel ligand and inhibitor types by means of protein X-ray crystallography and the identification of novel stabilizers of inactive conformations of p38α MAP kinase and of inhibitors of several phosphatases.Keywords
This publication has 45 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Structure-based design, synthesis and biological evaluation of N-pyrazole, N′-thiazole urea inhibitors of MAP kinase p38αEuropean Journal of Medicinal Chemistry, 2012
- A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment ChemotypesJournal of Medicinal Chemistry, 2011
- A comparative study of fragment screening methods on the p38α kinase: new methods, new insightsJournal of Computer-Aided Molecular Design, 2011
- Route to three-dimensional fragments using diversity-oriented synthesisProceedings of the National Academy of Sciences, 2011
- Using small molecules to target protein phosphatasesBioorganic & Medicinal Chemistry, 2011
- Biological Evaluation and Structural Determinants of p38α Mitogen‐Activated‐Protein Kinase and c‐Jun‐N‐Terminal Kinase 3 Inhibition by FlavonoidsChemBioChem, 2010
- Molecular Shape and Medicinal Chemistry: A PerspectiveJournal of Medicinal Chemistry, 2010
- Quantifying biogenic bias in screening librariesNature Chemical Biology, 2009
- Discovery of protein phosphatase inhibitor classes by biology-oriented synthesisProceedings of the National Academy of Sciences, 2006